Feed EW
EW

Edwards Lifesciences

EW · NYSE

$87.26 +2.48% (+$2.11)
1M -1.81%
Market Cap $50.2B
P/E Ratio 50.00x
Div. Yield -
ROE 9.69%

Bulios Fair Price

$52.3

40.1% downside

Trenutna cena

$87.26

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica EW trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Moderate
6/9
Valuation
15 /100
Expensive
P/E 50.00x
P/B 4.73x
EV/EBITDA 31.19x
Growth
41 /100
Stable
EPS growth 9.14%
Book val. growth 21.20%
Rev. growth 4.08%
Profitability
98 /100
Strong
Gross margin 77.98%
FCF margin 22.01%
Net margin 15.43%
Quality
52 /100
Average
ROIC 10.20%
Asset turnover 0.47x
ROE 9.69%
Debt
100 /100
Low
Debt/Equity 0.07x
Net debt/EBITDA -1.43x
Current ratio 4.52x
Stability
68 /100
Stable
Beta 0.85x
Profitable years 6
Rev. volatility 9.91%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o EW
Online

O podjetju

Edwards Lifesciences Corporation is an American company headquartered in Irvine, California. It specializes in the development, manufacturing, and sale of medical devices and technologies focused on the treatment of cardiovascular diseases. Their main products include innovative devices for surgical and interventional treatments of the heart and blood vessels, including valve replacements, surgical revascularization devices, monitoring systems, and more. Edwards Lifesciences Corporation is known for its advanced technologies and innovative products that contribute to the treatment of patients with cardiovascular diseases and improve their quality of life. The company has a global presence and is recognized as a leader in the field of cardiovascular medical technologies. Shares of Edwards Lifesciences Corporation are publicly traded on the NASDAQ stock exchange.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Bernard J. Zovighian

Employees

16,000

Headquarters

Irvine

Prihajajoči dogodki

29 OKT.

Earnings

Upcoming earnings report

23d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.